Before Prozac

Abstract Psychiatry today is a barren tundra, writes medical historian Edward Shorter, where drugs that don't work are used to treat diseases that don't exist. In this provocative volume, Shorter illuminates this dismal landscape, in a revealing account of why psychiatry is "losing gr...

Full description

Bibliographic Details
Main Author: Shorter, Edward
Format: Book
Language:English
Published: Oxford University PressNew York, NY 2008
Subjects:
Online Access:http://dx.doi.org/10.1093/oso/9780195368741.001.0001
id croxfordunivpr:10.1093/oso/9780195368741.001.0001
record_format openpolar
spelling croxfordunivpr:10.1093/oso/9780195368741.001.0001 2024-09-30T14:45:25+00:00 Before Prozac The Troubled History of Mood Disorders in Psychiatry Shorter, Edward 2008 http://dx.doi.org/10.1093/oso/9780195368741.001.0001 en eng Oxford University PressNew York, NY ISBN 9780195368741 9780197705728 edited-book 2008 croxfordunivpr https://doi.org/10.1093/oso/9780195368741.001.0001 2024-09-10T04:13:18Z Abstract Psychiatry today is a barren tundra, writes medical historian Edward Shorter, where drugs that don't work are used to treat diseases that don't exist. In this provocative volume, Shorter illuminates this dismal landscape, in a revealing account of why psychiatry is "losing ground" in the struggle to treat depression. Naturally, the book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: the FDA, the very agency charged with ensuring drug safety and effectiveness. Shorter describes how the FDA permits companies to test new products only against placebo. If you can beat sugar pills, you get your drug licensed, whether or not it is actually better than (or even as good as) current medications, thus sweeping from the shelves drugs that may be superior but have lost patent protection. The book also examines the FDA's early power struggles against the drug industry, an influence-grab that had little to do with science, and which left barbiturates, opiates, and amphetamines all underprescribed, despite the fact that under careful supervision they are better at treating depression, with fewer side effects, than the newer drugs in the Prozac family. Shorter also castigates academia, showing how two forms of depression, melancholia and nonmelancholia--"as different from each other as chalk and cheese"--became squeezed into one dubious classification, major depression, which was essentially a political artifact born of academic infighting. An astonishing and troubling look at modern psychiatry, Losing Ground is a book that is sure to spark controversy for years to come. Book Tundra Oxford University Press
institution Open Polar
collection Oxford University Press
op_collection_id croxfordunivpr
language English
description Abstract Psychiatry today is a barren tundra, writes medical historian Edward Shorter, where drugs that don't work are used to treat diseases that don't exist. In this provocative volume, Shorter illuminates this dismal landscape, in a revealing account of why psychiatry is "losing ground" in the struggle to treat depression. Naturally, the book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: the FDA, the very agency charged with ensuring drug safety and effectiveness. Shorter describes how the FDA permits companies to test new products only against placebo. If you can beat sugar pills, you get your drug licensed, whether or not it is actually better than (or even as good as) current medications, thus sweeping from the shelves drugs that may be superior but have lost patent protection. The book also examines the FDA's early power struggles against the drug industry, an influence-grab that had little to do with science, and which left barbiturates, opiates, and amphetamines all underprescribed, despite the fact that under careful supervision they are better at treating depression, with fewer side effects, than the newer drugs in the Prozac family. Shorter also castigates academia, showing how two forms of depression, melancholia and nonmelancholia--"as different from each other as chalk and cheese"--became squeezed into one dubious classification, major depression, which was essentially a political artifact born of academic infighting. An astonishing and troubling look at modern psychiatry, Losing Ground is a book that is sure to spark controversy for years to come.
format Book
author Shorter, Edward
spellingShingle Shorter, Edward
Before Prozac
author_facet Shorter, Edward
author_sort Shorter, Edward
title Before Prozac
title_short Before Prozac
title_full Before Prozac
title_fullStr Before Prozac
title_full_unstemmed Before Prozac
title_sort before prozac
publisher Oxford University PressNew York, NY
publishDate 2008
url http://dx.doi.org/10.1093/oso/9780195368741.001.0001
genre Tundra
genre_facet Tundra
op_source ISBN 9780195368741 9780197705728
op_doi https://doi.org/10.1093/oso/9780195368741.001.0001
_version_ 1811646093467844608